{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T00:02:35Z","timestamp":1790121755899,"version":"4.0.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T00:00:00Z","timestamp":1786924800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaloncologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.clon.2026.104313","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T06:43:45Z","timestamp":1785307425000},"page":"104313","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Analysis of Lymphopenia in Patients with Stage III Non-small Cell Lung Cancer Treated with Chemoradiotherapy and Consolidation Immunotherapy"],"prefix":"10.1016","volume":"58","author":[{"given":"L.","family":"Darbeau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-0575-5889","authenticated-orcid":false,"given":"T.","family":"Duroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9373-3929","authenticated-orcid":false,"given":"A.","family":"Alati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4789-7770","authenticated-orcid":false,"given":"E.","family":"Lanoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6130-6068","authenticated-orcid":false,"given":"C.","family":"Evin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Giraud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Guillerm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Wislez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Durdux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clon.2026.104313_bib1","doi-asserted-by":"crossref","first-page":"1919","DOI":"10.1056\/NEJMoa1709937","article-title":"Durvalumab after Chemoradiotherapy in Stage III Non\u2013Small-Cell Lung Cancer","volume":"377","author":"Antonia","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.clon.2026.104313_bib2","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1097\/JTO.0000000000000551","article-title":"Non\u2013Small Cell Lung Cancer: Role of the Immune System and Potential for Immunotherapy","volume":"10","author":"Carbone","year":"2015","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1200\/JCO.2012.45.8703","article-title":"Harnessing the immune system for the treatment of non-small-cell lung cancer","volume":"31","author":"Brahmer","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fonc.2013.00128","article-title":"Radiotherapy Effects on Anti-Tumor Immunity: Implications for Cancer Treatment","volume":"3","author":"Demaria","year":"2013","journal-title":"Front Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib5","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1038\/nm1622","article-title":"Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy","volume":"13","author":"Apetoh","year":"2007","journal-title":"Nat Med"},{"key":"10.1016\/j.clon.2026.104313_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1148692","article-title":"The current understanding of the immune landscape relative to radiotherapy across tumor types","volume":"14","author":"Iliadi","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/j.clon.2026.104313_bib7","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1158\/1078-0432.728.11.2","article-title":"Immune-Mediated Inhibition of Metastases after Treatment with Local Radiation and CTLA-4 Blockade in a Mouse Model of Breast Cancer","volume":"11","author":"Demaria","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clon.2026.104313_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.bbcan.2014.04.009","article-title":"Radiation sensitivity of human and murine peripheral blood lymphocytes, stem and progenitor cells","volume":"1846","author":"Heylmann","year":"2014","journal-title":"Biochim Biophys Acta (BBA) - Rev Cancer"},{"key":"10.1016\/j.clon.2026.104313_bib9","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2307\/3577549","article-title":"Radiosensitivity of CD4 or CD8 Positive Human T-Lymphocytes by an in Vitro Colony Formation Assay","volume":"123","author":"Nakamura","year":"1990","journal-title":"Radiat Res"},{"key":"10.1016\/j.clon.2026.104313_bib10","doi-asserted-by":"crossref","first-page":"3139","DOI":"10.1111\/1759-7714.13621","article-title":"Impacts of post-radiotherapy lymphocyte count on progression-free and overall survival in patients with stage III lung cancer","volume":"11","author":"Matiello","year":"2020","journal-title":"Thorac Cancer"},{"key":"10.1016\/j.clon.2026.104313_bib11","doi-asserted-by":"crossref","first-page":"183","DOI":"10.3109\/07357907.2013.767342","article-title":"Treatment-related Lymphopenia in Patients With Stage III Non-Small-Cell Lung Cancer","volume":"31","author":"Campian","year":"2013","journal-title":"Cancer Invest"},{"key":"10.1016\/j.clon.2026.104313_bib12","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.adro.2018.08.014","article-title":"Field size effects on the risk and severity of treatment-induced lymphopenia in patients undergoing radiation therapy for solid tumors","volume":"3","author":"Ellsworth","year":"2018","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib13","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.ijrobp.2018.09.010","article-title":"The Impact of Radiation Therapy on Lymphocyte Count and Survival in Metastatic Cancer Patients Receiving PD-1 Immune Checkpoint Inhibitors","volume":"103","author":"Pike","year":"2019","journal-title":"Int J Radiat Oncology\u2217Biology\u2217Physics"},{"key":"10.1016\/j.clon.2026.104313_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5306\/wjco.v8.i1.1","article-title":"Therapeutic management options for stage III non-small cell lung cancer","volume":"8","author":"Yoon","year":"2017","journal-title":"World J Clin Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib15","doi-asserted-by":"crossref","first-page":"5473","DOI":"10.1158\/1078-0432.CCR-11-0774","article-title":"Immunosuppression in Patients with High Grade Gliomas Treated with Radiation and Temozolomide","volume":"17","author":"Grossman","year":"2011","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.clon.2026.104313_bib16","first-page":"3541","article-title":"Prognostic Value of Severe Lymphopenia During Pelvic Concurrent Chemoradiotherapy in Cervical Cancer","volume":"36","author":"Cho","year":"2016","journal-title":"Anticancer Res"},{"key":"10.1016\/j.clon.2026.104313_bib17","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s12094-018-1908-2","article-title":"The absolute lymphocyte count can predict the overall survival of patients with non-small cell lung cancer on nivolumab: a clinical study","volume":"21","author":"Karantanos","year":"2019","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib18","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-019-0549-5","article-title":"Lymphopenia in Cancer Patients and its Effects on Response to Immunotherapy: an opportunity for combination with Cytokines?","volume":"7","author":"M\u00e9n\u00e9trier-Caux","year":"2019","journal-title":"J Immunother Cancer"},{"key":"10.1016\/j.clon.2026.104313_bib19","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/j.clon.2026.104313_bib20","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.radonc.2021.01.034","article-title":"Risk and impact of radiation related lymphopenia in lung cancer: A systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib21","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1186\/s13014-019-1287-z","article-title":"Treatment-duration is related to changes in peripheral lymphocyte counts during definitive radiotherapy for unresectable stage III NSCLC","volume":"14","author":"Zhao","year":"2019","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib22","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4068\/cmj.2024.60.1.40","article-title":"Blood Lymphocytes as a Prognostic Factor for Stage III Non-Small Cell Lung Cancer with Concurrent Chemoradiation","volume":"60","author":"Kim","year":"2024","journal-title":"Chonnam Med J"},{"key":"10.1016\/j.clon.2026.104313_bib23","article-title":"Severe Radiation-Induced Lymphopenia Attenuates the Benefit of Durvalumab After Concurrent Chemoradiotherapy for NSCLC","volume":"3","author":"Jing","year":"2022","journal-title":"JTO Clin Res Rep"},{"key":"10.1016\/j.clon.2026.104313_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2022.01.007","article-title":"Lymphocyte dynamics during and after chemo-radiation correlate to dose and outcome in stage III NSCLC patients undergoing maintenance immunotherapy","volume":"168","author":"Cho","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2023.1278723","article-title":"Severe radiation-induced lymphopenia during concurrent chemoradiotherapy for stage III non-small cell lung cancer: external validation of two prediction models","volume":"13","author":"van Rossum","year":"2023","journal-title":"Front Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib26","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/j.ijrobp.2014.04.025","article-title":"Lymphopenia association with gross tumor volume and lung V5 and its effects on non-small cell lung cancer patient outcomes","volume":"89","author":"Tang","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2026.104313_bib27","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.radonc.2020.05.051","article-title":"Corrigendum to \u201cInteraction between lymphopenia, radiotherapy technique, dosimetry, and survival outcomes in lung cancer patients receiving combined immunotherapy and radiotherapy\u201d","volume":"150","author":"Chen","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib28","first-page":"47","article-title":"Effect of Lymphopenia on Tumor Response and Clinical Outcomes Following Chemoradiotherapy in Stage III Non-Small Cell Lung Cancer","volume":"14","author":"Deck","year":"2023","journal-title":"Lung Cancer (Auckl)"},{"key":"10.1016\/j.clon.2026.104313_bib29","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.ijrobp.2019.08.047","article-title":"Impact of Treatment-Related Lymphopenia on Immunotherapy for Advanced Non-Small Cell Lung Cancer","volume":"105","author":"Cho","year":"2019","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.clon.2026.104313_bib30","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.ijrobp.2019.07.013","article-title":"Lymphocyte Count Kinetics, Factors Associated with the End-of-Radiation-Therapy Lymphocyte Count, and Risk of Infection in Patients with Solid Malignant Tumors Treated with Curative-Intent Radiation Therapy","volume":"105","author":"Terrones-Campos","year":"2019","journal-title":"Int J Radiat Oncology\u2217Biology\u2217Physics"},{"key":"10.1016\/j.clon.2026.104313_bib31","article-title":"Dosimetric Effect of Thymus and Thoracic Duct on Radiation-Induced Lymphopenia in Patients With Primary Lung Cancer Who Received Thoracic Radiation","volume":"8","author":"Zhang","year":"2023","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib32","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1016\/j.ijrobp.2019.05.064","article-title":"Impact of Radiation Dose to the Host Immune System on Tumor Control and Survival for Stage III Non-Small Cell Lung Cancer Treated with Definitive Radiation Therapy","volume":"105","author":"Ladbury","year":"2019","journal-title":"Int J Radiat Oncology\u2217Biology\u2217Physics"},{"key":"10.1016\/j.clon.2026.104313_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.109934","article-title":"Risk of on-treatment lymphopenia is associated with treatment outcome and efficacy of consolidation immunotherapy in patients with non-small cell lung cancer treated with concurrent chemoradiotherapy","volume":"189","author":"Yang","year":"2023","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.clon.2026.104313_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.radonc.2023.110030","article-title":"The effective radiation dose to immune cells predicts lymphopenia and inferior cancer control in locally advanced NSCLC","volume":"190","author":"Friedes","year":"2024","journal-title":"Radiother Oncol"}],"container-title":["Clinical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526002840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0936655526002840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:26:06Z","timestamp":1790119566000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0936655526002840"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S0936655526002840"],"URL":"https:\/\/doi.org\/10.1016\/j.clon.2026.104313","relation":{},"ISSN":["0936-6555"],"issn-type":[{"value":"0936-6555","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of Lymphopenia in Patients with Stage III Non-small Cell Lung Cancer Treated with Chemoradiotherapy and Consolidation Immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Clinical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clon.2026.104313","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd on behalf of The Royal College of Radiologists.","name":"copyright","label":"Copyright"}],"article-number":"104313"}}